Bzo-poxizid-d9

Bzo-poxizid-d9 (5C-MDA-19-d9, Petyl MDA-19-d9) is deuterium labeled Bzo-poxizid. Bzo-poxizid is a synthetic cannabinoid that is a psychoactive substance[1][2].

Product Specifications

Product Name Alternative

5C-MDA-19-d9, Petyl MDA-19-d9

UNSPSC

12352005

Target

Cannabinoid Receptor; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

GPCR/G Protein; Neuronal Signaling; Others

Field of Research

Neurological Disease

Smiles

O=C(C1=CC=CC=C1)N/N=C2C(N(C3=C\2C=CC=C3)CC([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])=O

Molecular Formula

C20H12D9N3O2

Molecular Weight

344.46

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Shimpei Watanabe, et al. Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID. J Anal Toxico. 2023 May 19;47 (5) :455-463.